SCHEMBL6027258

SCHEMBL6027258

O=Cc1c(O)cccc1OCCCCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 3/20 0.45
LTB4R2 Q9NPC1 3/20 0.45
PPARA Q07869 2/20 0.43
ALB P02768 1/20 0.43
CNR2 P34972 3/20 0.42
ALDH1A1 P00352 2/20 0.41
CNR1 P21554 2/20 0.41
LMNA P02545 2/20 0.41
JAK2 O60674 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
FABP1 P07148 1/20 0.40
TBXA2R P21731 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026140 1.00 LTB4R (0.45) LTB4RLTB4R2PPARAALBCNR2
Velaresol SCHEMBL61907 0.99 PPARA (0.44) LTB4RLTB4R2PPARAALBCNR2
SCHEMBL6026502 0.94 TSHR (0.44) LTB4RLTB4R2PPARAALDH1A1LMNA
SCHEMBL6026753 0.87 LMNA (0.42) LTB4RLTB4R2CNR2ALDH1A1CNR1
Velaresol SCHEMBL11157225 0.85 CNR2 (0.45) CNR2ALDH1A1CNR1PTGDR2
Velaresol SCHEMBL11149918 0.84 PPARG (0.45) PPARACNR2ALDH1A1CNR1LMNA
SCHEMBL10921040 0.83 SMN1; SMN2 (0.42) LTB4RLTB4R2PPARACNR2ALDH1A1
SCHEMBL11149422 0.83 LMNA (0.55) LTB4RLTB4R2PPARACNR2ALDH1A1
SCHEMBL10926348 0.83 CNR1 (0.43) CNR2ALDH1A1CNR1
SCHEMBL24080812 0.82 GAA (0.50) CNR2ALDH1A1CNR1LMNAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
CN-1326358-A Method of DNA vaccination GLAXO GROUP LTD (GB) 2001-12-12 CN claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
CN-1326358-A Method of DNA vaccination GLAXO GROUP LTD (GB) 2001-12-12 CN disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed
EP-0054924-B1 PHARMACEUTICAL COMPOUNDS, THEIR PREPARATION AND USE THE WELLCOME FOUNDATION LIMITED (GB) 1986-08-06 EP disclosed
US-4535183-A PALLIATION OF SICKLE CELL ANEMIA, RESPIRATORY DISORDERS, HYPOXIA, RADIOSENSITIZATION OF TUMORS BURROUGHS WELLCOME CO. (US) 1985-08-13 US disclosed
EP-0054924-A2 Pharmaceutical compounds, their preparation and use THE WELLCOME FOUNDATION LIMITED (GB) 1982-06-30 EP disclosed